SHARE PURCHASE AGREEMENTShare Purchase Agreement • September 8th, 2021 • Xenon Pharmaceuticals Inc. • Pharmaceutical preparations • New York
This Share Purchase Agreement (this “Agreement”), is made as of September 8, 2021 (the “Signing Date”), by and between Neurocrine Biosciences, Inc. (the “Investor”), a Delaware corporation, and Xenon Pharmaceuticals Inc. (the “Company”), a Canadian corporation.
